Evidence mapPaperPMID 37791289Full record

ReviewBiomedical optics express2023

OCT angiography and its retinal biomarkers [Invited].

Tristan T Hormel, Yali Jia

Abstract readReview
In one paragraph

Review in Biomedical optics express, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Clinically Explainable Disease Diagnosis Based on Biomarker Activation Map.IEEE transactions on bio-medical engineering · 2026
    Article
  2. Strip-Scanning for Efficient Widefield Retinal OCTA Mosaicking.Translational vision science & technology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Advances in OCT Angiography.Translational vision science & technology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tristan T HormelCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA.
Yali JiaCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0000-0002-2784-1905

Funding

Oregon Clinical and Translational Research InstituteUL1TR002369 · OREGON HEALTH & SCIENCE UNIVERSITY · 2025 to 2025
$9.9M
NCATS NIH HHS UL1 TR002369
6 · The paper itself

Abstract

Optical coherence tomography angiography (OCTA) is a high-resolution, depth-resolved imaging modality with important applications in ophthalmic practice. An extension of structural OCT, OCTA enables non-invasive, high-contrast imaging of retinal and choroidal vasculature that are amenable to quantification. As such, OCTA offers the capability to identify and characterize biomarkers important for clinical practice and therapeutic research. Here, we review new methods for analyzing biomarkers and discuss new insights provided by OCTA.

Identifiers

PMID37791289
PMCPMC10545210

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.